Choi, Alex S.
Jenkins-Lane, Laura M.
Barton, Wade
Kumari, Asha
Lancaster, Carly
Raulerson, Calen
Ji, Hao
Altomare, Diego
Starr, Mark D.
Whitaker, Regina
Phaeton, Rebecca
Arend, Rebecca
Shtutman, Michael
Nixon, Andrew B.
Hempel, Nadine
Lee, Nam Y.
Mythreye, Karthikeyan
Funding for this research was provided by:
National Institutes of Health (R01CA219495, R01CA219495, R01CA219495, R01CA219495, R01CA219495, R01CA219495, R01CA219495)
Article History
Received: 14 September 2023
Accepted: 21 January 2024
First Online: 15 February 2024
Declarations
:
: The authors declare no competing interests.
: Specimens from patients diagnosed with primary ovarian cancer were collected and banked after informed consent at Duke University Medical Center, Pennsylvania State University College of Medicine (Hershey, PA), or the University of Alabama Birmingham, with approval for the study grant from the Duke University’s institutional research ethics board, Penn State College of Medicine and UAB Institutional Review Boards (IRB) respectively.
: Not applicable.
: The authors declare no competing interests.